
Australian Pharmaceutical Industries Ltd
ASX:API

Australian Pharmaceutical Industries Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Australian Pharmaceutical Industries Ltd hold over its rivals?
What risks and challenges
does Australian Pharmaceutical Industries Ltd face in the near future?
Provide an overview of the primary business activities
of Australian Pharmaceutical Industries Ltd.
Show me price targets
for Australian Pharmaceutical Industries Ltd made by professional analysts.
Provide an overview of the primary business activities
of Australian Pharmaceutical Industries Ltd.
What unique competitive advantages
does Australian Pharmaceutical Industries Ltd hold over its rivals?
What risks and challenges
does Australian Pharmaceutical Industries Ltd face in the near future?
Show all valuation multiples
for Australian Pharmaceutical Industries Ltd.
Provide P/S
for Australian Pharmaceutical Industries Ltd.
Provide P/E
for Australian Pharmaceutical Industries Ltd.
Provide P/OCF
for Australian Pharmaceutical Industries Ltd.
Provide P/FCFE
for Australian Pharmaceutical Industries Ltd.
Provide P/B
for Australian Pharmaceutical Industries Ltd.
Provide EV/S
for Australian Pharmaceutical Industries Ltd.
Provide EV/GP
for Australian Pharmaceutical Industries Ltd.
Provide EV/EBITDA
for Australian Pharmaceutical Industries Ltd.
Provide EV/EBIT
for Australian Pharmaceutical Industries Ltd.
Provide EV/OCF
for Australian Pharmaceutical Industries Ltd.
Provide EV/FCFF
for Australian Pharmaceutical Industries Ltd.
Provide EV/IC
for Australian Pharmaceutical Industries Ltd.
Show me price targets
for Australian Pharmaceutical Industries Ltd made by professional analysts.
What are the Revenue projections
for Australian Pharmaceutical Industries Ltd?
How accurate were the past Revenue estimates
for Australian Pharmaceutical Industries Ltd?
What are the Net Income projections
for Australian Pharmaceutical Industries Ltd?
How accurate were the past Net Income estimates
for Australian Pharmaceutical Industries Ltd?
What are the EPS projections
for Australian Pharmaceutical Industries Ltd?
How accurate were the past EPS estimates
for Australian Pharmaceutical Industries Ltd?
What are the EBIT projections
for Australian Pharmaceutical Industries Ltd?
How accurate were the past EBIT estimates
for Australian Pharmaceutical Industries Ltd?
Compare the revenue forecasts
for Australian Pharmaceutical Industries Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Australian Pharmaceutical Industries Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Australian Pharmaceutical Industries Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Australian Pharmaceutical Industries Ltd compared to its peers.
Compare the P/E ratios
of Australian Pharmaceutical Industries Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Australian Pharmaceutical Industries Ltd with its peers.
Analyze the financial leverage
of Australian Pharmaceutical Industries Ltd compared to its main competitors.
Show all profitability ratios
for Australian Pharmaceutical Industries Ltd.
Provide ROE
for Australian Pharmaceutical Industries Ltd.
Provide ROA
for Australian Pharmaceutical Industries Ltd.
Provide ROIC
for Australian Pharmaceutical Industries Ltd.
Provide ROCE
for Australian Pharmaceutical Industries Ltd.
Provide Gross Margin
for Australian Pharmaceutical Industries Ltd.
Provide Operating Margin
for Australian Pharmaceutical Industries Ltd.
Provide Net Margin
for Australian Pharmaceutical Industries Ltd.
Provide FCF Margin
for Australian Pharmaceutical Industries Ltd.
Show all solvency ratios
for Australian Pharmaceutical Industries Ltd.
Provide D/E Ratio
for Australian Pharmaceutical Industries Ltd.
Provide D/A Ratio
for Australian Pharmaceutical Industries Ltd.
Provide Interest Coverage Ratio
for Australian Pharmaceutical Industries Ltd.
Provide Altman Z-Score Ratio
for Australian Pharmaceutical Industries Ltd.
Provide Quick Ratio
for Australian Pharmaceutical Industries Ltd.
Provide Current Ratio
for Australian Pharmaceutical Industries Ltd.
Provide Cash Ratio
for Australian Pharmaceutical Industries Ltd.
What is the historical Revenue growth
over the last 5 years for Australian Pharmaceutical Industries Ltd?
What is the historical Net Income growth
over the last 5 years for Australian Pharmaceutical Industries Ltd?
What is the current Free Cash Flow
of Australian Pharmaceutical Industries Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Australian Pharmaceutical Industries Ltd.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
AU |
![]() |
Australian Pharmaceutical Industries Ltd
ASX:API
|
753.8m AUD | 41.1 | |
US |
![]() |
Mckesson Corp
NYSE:MCK
|
89B USD | 19.7 |
|
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
56.9B USD | 19.4 |
|
US |
![]() |
Cencora Inc
NYSE:COR
|
56.7B USD | 19.4 |
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
37.5B USD | 17.2 |
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
33B AUD | 1 529.4 |
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
75.4B CNY | 16.6 |
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
70.8B CNY | 10.8 |
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
9.1B USD | 15.1 |
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 61.9 |
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD | 30.2 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
AU |
![]() |
Australian Pharmaceutical Industries Ltd
ASX:API
|
Average EV/EBIT:
161.9
41.1
|
N/A | N/A | |
US |
![]() |
Mckesson Corp
NYSE:MCK
|
19.7
|
18%
|
1.1 |
|
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
19.4
|
17%
|
1.1 |
|
US |
![]() |
Cencora Inc
NYSE:COR
|
19.4
|
17%
|
1.1 |
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
17.2
|
16%
|
1.1 |
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
1 529.4
|
N/A | N/A |
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
16.6
|
12%
|
1.4 |
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
10.8
|
9%
|
1.2 |
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
15.1
|
14%
|
1.1 |
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
61.9
|
38%
|
1.6 |
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
30.2
|
7%
|
4.3 |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.